Last reviewed · How we verify
Inactivated rabies virus vaccine
Inactivated rabies virus vaccine is a Biologic drug developed by Sanofi Pasteur, a Sanofi Company. It is currently in Phase 2 development. Also known as: Verorab®.
At a glance
| Generic name | Inactivated rabies virus vaccine |
|---|---|
| Also known as | Verorab® |
| Sponsor | Sanofi Pasteur, a Sanofi Company |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
- Headache
- Malaise
- Injection Site Pain
- Myalgia
- Nasopharyngitis
- Vaccination site pain
- Fatigue
- Feeling of body temperature change
- White blood cell count decreased
- Arthralgia
- Nausea
- Pyrexia
Key clinical trials
- A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M (PHASE2)
- Pfs230D1 + R21 in Matrix-M1 in African School Children and Adults (PHASE2)
- Safety and Immunogenicity of Coadministration of the Candidate Rabies Vaccine ChAdOx2 RabG and Licensed Vaccine (PHASE2)
- A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG (PHASE1, PHASE2)
- Vaccine Responsiveness After CAR-T Cell Therapy (PHASE1)
- A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy Adults (PHASE1)
- Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical Trials (PHASE2)
- Dosage-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Inactivated rabies virus vaccine CI brief — competitive landscape report
- Inactivated rabies virus vaccine updates RSS · CI watch RSS
- Sanofi Pasteur, a Sanofi Company portfolio CI
Frequently asked questions about Inactivated rabies virus vaccine
What is Inactivated rabies virus vaccine?
Inactivated rabies virus vaccine is a Biologic drug developed by Sanofi Pasteur, a Sanofi Company.
Who makes Inactivated rabies virus vaccine?
Inactivated rabies virus vaccine is developed by Sanofi Pasteur, a Sanofi Company (see full Sanofi Pasteur, a Sanofi Company pipeline at /company/sanofi).
Is Inactivated rabies virus vaccine also known as anything else?
Inactivated rabies virus vaccine is also known as Verorab®.
What development phase is Inactivated rabies virus vaccine in?
Inactivated rabies virus vaccine is in Phase 2.
What are the side effects of Inactivated rabies virus vaccine?
Common side effects of Inactivated rabies virus vaccine include Headache, Malaise, Injection Site Pain, Myalgia, Nasopharyngitis, Vaccination site pain.
Related
- Manufacturer: Sanofi Pasteur, a Sanofi Company — full pipeline
- Also known as: Verorab®
- Compare: Inactivated rabies virus vaccine vs similar drugs
- Pricing: Inactivated rabies virus vaccine cost, discount & access